Ascorbate (Asc) reductions of the oral anticancer platinum() prodrugs cis,trans,cis-[PtCl 2 (OAc) 2 (cha)(NH 3 )] (JM216) and cis,trans,cis-[PtCl 2 (OCOC 3 H 7 ) 2 (cha)(NH 3 )] (JM221) and of the isomers of JM216, viz. trans,cis,cis-[PtCl 2 (OAc) 2 (cha)(NH 3 )] (JM394) and trans,trans,trans-[PtCl 2 (OAc) 2 (cha)(NH 3 )] (JM576) (OAc = acetate, cha = cyclohexylamine) have been investigated in a 1.0 M aqueous perchlorate medium using stopped-flow and conventional UV/VIS spectrophotometry as a function of temperature and pH. JM216 and 221 are reduced to cis-[PtCl 2 (cha)(NH 3 )] (JM118) and JM394 and 576 to cis-and trans-[Pt(OAc) 2 (cha)(NH 3 )], respectively. The redox reactions follow the second-order rate law:where k is a pH dependent second-order overall rate constant andReduction of JM216 and JM221 is slow (overall rate constants k 298 = 5.08 ± 10 Ϫ2 and 3.25 × 10 Ϫ2 mol Ϫ1 dm 3 s Ϫ1 at pH 7.12, respectively) and is suggested to take place via an outer-sphere mechanism. Reductions of JM394 and JM576 are more than three orders of magnitude faster (k 298 = 230 ± 6 mol Ϫ1 dm 3 s Ϫ1 at pH 7.0 for JM394). They are suggested to take place by a mechanism involving a reductive attack on one of the mutually trans chloride ligands by Asc 2Ϫ and less efficiently by HAsc Ϫ leading to the formation of a chloride-bridged activated complex. The second-order rate constants for reduction of JM394 by HAsc Ϫ and Asc 2Ϫ at 25 ЊC are 0.548 ± 0.004 and (4.46 ± 0.01) × 10 6 mol Ϫ1 dm 3 s Ϫ1 , respectively. The rate constants for reduction of JM216 and JM221 by Asc 2Ϫ at 25 ЊC are calculated to be 672 ± 15 and 428 ± 10 mol Ϫ1 dm 3 s Ϫ1 , respectively and reduction by HAsc Ϫ was not observed under these conditions. Thus, Asc 2Ϫ is up to 7 orders of magnitude more efficient as a reductant than HAsc Ϫ . H 2 Asc is virtually inactive. The activation parameters ∆H ‡ and ∆S ‡ for reduction of JM216, JM221, JM394, and JM576 by Asc 2Ϫ are 52 ± 1, 46 ± 1, 56.2 ± 0.5, and 63 ± 2 kJ mol Ϫ1 and Ϫ97 ± 4, Ϫ120 ± 4, Ϫ24 ± 2, and Ϫ8 ± 5 J K Ϫ1 mol Ϫ1 , respectively. An isokinetic relationship gives further support to the mechanistic assignments.

The reduction of the platinum(IV) prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by L-cysteine, DL-penicillamine, DL-homocysteine, N-acetyl-L-cysteine, 2-mercaptopropanoic acid, 2-mercaptosuccinic acid, and glutathione has been investigated at 25 degrees C in a 1.0 M aqueous perchlorate medium with 6.8 < or = pH < or = 11.2 using stopped-flow spectrophotometry. The stoichiometry of Pt(IV):thiol is 1:2, and the redox reactions follow the second-order rate law -d[Pt(IV)]/dt = k[Pt(IV)][RSH]tot, where k denotes the pH-dependent second-order rate constant and [RSH]tot the total concentration of thiol. The pH dependence of k is ascribed to parallel reductions of JM335 by the various protolytic species of the thiols, the relative contributions of which change with pH. Electron transfer from thiol (RSH) or thiolate (RS-) to JM335 is suggested to take place as a reductive elimination process through an attack by sulfur at one of the mutually trans chloride ligands, yielding trans-[Pt(OH)2(c-C6H11NH2)(NH3)] and RSSR as the reaction products, as confirmed by 1H NMR. Second-order rate constants for the reduction of JM335 by the various protolytic species of the thiols span more than 3 orders of magnitude. Reduction with RS- is approximately 30-2000 times faster than with RSH. The linear correlation log(kRS) = (0.52 +/- 0.06)-pKRSH--(2.8 +/- 0.5) is observed, where kRS denotes the second-order rate constant for reduction of JM335 by a particular thiolate RS- and KRSH is the acid dissociation constant for the corresponding thiol RSH. The slope of the linear correlation indicates that the reactivity of the various thiolate species is governed by their proton basicity, and no significant steric effects are observed. The half-life for reduction of JM335 by 6 mM glutathione (40-fold excess) at physiologically relevant conditions of 37 degrees C and pH 7.30 is 23 s. This implies that JM335, in clinical use, is likely to undergo in vivo reduction by intracellular reducing agents such as glutathione prior to binding to DNA. Reduction results in the immediate formation of a highly reactive platinum(II) species, i.e., the bishydroxo complex in rapid protolytic equilibrium with its aqua form.

Glutathione (GSH) reduction of the anticancer-active platinum(IV) compounds trans-[PtCl4(NH3)(thiazole)] (1), trans-[PtCl4(cha)(NH3)] (2), cis-[PtCl4(cha)(NH3)] (3) (cha=cyclohexylamine), and cis-[PtCl4(NH3)2] (4) has been investigated at 25 degrees C in a 1.0 M aqueous medium at pH 2.0-5.0 (1) and 4.5-6.8 (2-4) using stopped-flow spectrophotometry. The redox reactions follow the second-order rate law d[Pt(IV)]/dt=k[GSH]tot[Pt(IV)], where k is a pH-dependent rate constant and [GSH]tot the total concentration of glutathione. The reduction takes place via parallel reactions between the platinum(IV) complexes and the various protolytic species of glutathione. The pH dependence of the redox kinetics is ascribed to displacement of these protolytic equilibria. The thiolate species GS is the major reductant under the reaction conditions used. The second-order rate constants for reduction of compounds 1-4 by GS- are (1.43 +/- 0.01) x 10(7), (3.86 +/- 0.03) x 10(6), (1.83 +/- 0.01) x 10(6), and (1.18 +/- 0.01) x 10(6) M(-1)s(-1), respectively. Rate constants for reduction of 1 by the protonated species GSH are more than five orders of magnitude smaller. The mechanism for the reductive elimination reactions of the Pt(IV) compounds is proposed to involve an attack by glutathione on one of the mutually trans coordinated chloride ligands, leading to two-electron transfer via a chloride-bridged activated complex. The kinetics results together with literature data indicate that platinum(IV) complexes with a trans Cl-Pt-Cl axis are reduced rapidly by glutathione as well as by ascorbate. In agreement with this observation, cytotoxicity profiles for such complexes are very similar to those for the corresponding platinum(II) product complexes. The rapid reduction within 1 s of the platinum(IV) compounds with a trans Cl-Pt-C1 axis to their platinum(II) analogs does not seem to support the strategy of using kinetic inertness as a parameter to increase anticancer activity, at least for this class of compounds.

The kinetics of comproportionation of hypothiocyanous acid (HOSCN) and thiocyanate (SCN-) to give thiocyanogen ((SCN)2) in acidic aqueous solutions have been determined by double-mixing stopped-flow UV spectroscopy. Hypothiocyanite (OSCN-) was generated at pH 13 by oxidation of excess SCN- with hypobromite (OBr-), followed by a pH jump to acidic conditions ([H+] = 0.20-0.46 M). The observed pseudo-first-order rate constants exhibit first-order dependencies on [H+] and [SCN-] with overall third-order kinetics. The corresponding kinetics of hydrolysis of (SCN)2 have also been examined. Under conditions of high (and constant) [H+] and [SCN-], the kinetics exhibit second-order behavior with respect to [(SCN)2] and complex inverse dependences on [H+] and [SCN-]. Under conditions of low [H+] and [SCN-], the kinetics exhibit first-order behavior with respect to [(SCN)2] and independence with respect to [H+] and [SCN-]. We attribute this behavior to a shift in the rate-limiting step from disproportionation of HOSCN (second-order dependency on [(SCN)2]) to rate-limiting hydrolysis (first-order dependency on [(SCN)2]). Thus, we have determined the following equilibrium constant by the kinetic method: (SCN)2 + H2O HOSCN + SCN- + H+; Khyd = [HOSCN][SCN-][H+]/[(SCN)2] = khyd/kcomp = 19.8(+/-0.7) s-1/ 5.14(+/-0.07) x 103 M-2 s-1 = 3.9 x 10-3 M2.

No abstract

The kinetics and mechanisms of the reaction of cysteine with cysteine thiosulfinate ester in aqueous solution have been studied by stopped-flow spectrophotometry between pH 6 and 14. Two reaction pathways were observed for pH > 12: (1) an essentially pH-independent nucleophilic attack of cysteinate on cysteine thiosulfinate ester, and (2) a pH-dependent fast equilibrium protonation of cysteine sulfenate that is followed by rate-limiting comproportionation of cysteine sulfenic acid with cysteinate to give cystine. For 6 < pH < 12, the rate-determining reaction between cysteinate and cysteine thiosulfinate ester becomes pH-dependent due to the protonation of their amine groups. Hydrolysis of cysteine thiosulfinate ester does not play a role in the aforementioned mechanisms because the rate-determining nucleophilic attack by hydroxide is relatively slow.

A mesoporous silica-supported uranyl material (U(aq)O(2)(2+)-silica) was prepared by a co-condensation method. Our approach involves an I(-)M(+)S(-) scheme, where the electrostatic interaction between the anionic inorganic precursor (I(-)), surfactant (S(-)), and cationic mediator (M(+)) provides the basis for the stability of the composite material. The synthesis was carried out under acidic conditions, where the anionic sodium dodecyl sulfate provided the template for the uranyl cation and silicate to condense. Excitation with visible or near-UV light of aqueous suspensions of U(aq)O(2)(2+)-silica generates an excited state that decays with k(0) = 1.5 x 10(4) s(-1). The reaction of the excited state with aliphatic alcohols exhibits kinetic saturation and concentration-dependent kinetic isotope effects. For 2-propanol, the value of k(C)3(H)7(OH)/k(C)()3(D)7(OH) decreases from 2.0 at low alcohol concentrations to 1.0 in the saturation regime at high alcohol concentrations. Taken together, the data describe a kinetic system controlled by chemical reaction at one extreme and diffusion at the other. At low [alcohol], the second-order rate constants for the reaction of silica-U(aq)O(2)(2+) with methanol, 2-propanol, 2-butanol, and 2-pentanol are comparable to the rate constants obtained for these alcohols in homogeneous aqueous solutions containing H(3)PO(4). Under slow steady-state photolysis in O(2)-saturated suspensions, U(aq)O(2)(2+)-silica acts as a photocatalyst for the oxidation of alcohols with O(2).

Hypothiocyanite (OSCN-) hydrolyzes under alkaline conditions to give thiocarbamate-S-oxide (H2NC(=O)SO-, the conjugate base of carbamothioperoxoic acid) via a mechanism that involves rate-limiting nucleophilic attack of OH- on OSCN-, followed by fast protonation (with no net consumption of H+/OH- at pH 11.7). Thiocarbamate-S-oxide has been characterized by 13C NMR, 15N NMR, UV spectroscopy, and ion chromatography. It has also been independently synthesized by the reaction of thiocarbamate (H2NC(=O)S-) and hypochlorite (OCl-). The properties of thiocarbamate-S-oxide that is produced by hydrolysis of OSCN- and by oxidation of H2NC(=O)S- are the same. The possible relevance of thiocarbamate-S-oxide in human peroxidase defense mechanisms remains to be explored.